Hodgkin's disease following extranodal marginal zone B-cell lymphoma in remission

International Journal of Hematology

Volumn 69, Issue 2, 1999, Pages 96-100

  Shimizu, Kazuyuki ^a   Hara, Kazuo ^b   Yatabe, Yasushi ^c  

^a Nagoya City Higashi General Hospital   (Japan)

^b AICHI MEDICAL UNIVERSITY HOSPITAL   (Japan)

^c AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Causal relation; DNA analyses; Hodgkin's disease; Immunophenotype; Marginal zone B cell lymphoma

Indexed keywords

ANTINEOPLASTIC AGENT; CD20 ANTIGEN; CHOP PROTOCOL; CYCLOPHOSPHAMIDE; DOXORUBICIN; LYMPHOCYTE ANTIGEN RECEPTOR; PREDNISONE; TUMOR MARKER; TUMOR PROTEIN; VINCRISTINE; VIRUS RNA;

CANCER STEM CELL; CASE REPORT; CHEMISTRY; DIFFERENTIAL DIAGNOSIS; EPSTEIN BARR VIRUS; FATALITY; FEMALE; GENE REARRANGEMENT; HODGKIN DISEASE; HUMAN; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; ISOLATION AND PURIFICATION; LYMPHOCYTOMA; MIDDLE AGED; MIXED CELL LYMPHOMA; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; MULTIMODALITY CANCER THERAPY; PATHOLOGY; POLYMERASE CHAIN REACTION; REED STERNBERG CELL; REMISSION; REVIEW; SECOND CANCER; VIRUS INFECTION;

ANTIGENS, CD20; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DIAGNOSIS, DIFFERENTIAL; DOXORUBICIN; EPSTEIN-BARR VIRUS INFECTIONS; FATAL OUTCOME; FEMALE; GENE REARRANGEMENT; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; LYMPHOMA, MIXED-CELL; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; LYMPHOMA, SMALL CLEAVED-CELL, DIFFUSE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASMS, SECOND PRIMARY; POLYMERASE CHAIN REACTION; PREDNISONE; RECEPTORS, ANTIGEN, B-CELL; REED-STERNBERG CELLS; REMISSION INDUCTION; RNA, VIRAL; TUMOR MARKERS, BIOLOGICAL; TUMOR STEM CELLS; VINCRISTINE;

EID: 0033072991     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Williams J, Schned A, Cotelingam JD, Jaffe ES. Chronic lymphocytic leukemia with coexistent Hodgkin's disease. Am J Surg Pathol 1991;15:33-42.
2. Zarate-Osorno A, Medeiros LJ, Kingma DW, Longo DL, Jaffe ES. Hodgkin's disease following non-Hodgkin's lymphoma. A clinicopathologic and immunophenotypic study of nine cases. Am J Surg Pathol 1993;17:123-32.
3. Kingma DW, Medeiros LJ, Barletta J, et al. Epstein-Barr virus is infrequently identified in non-Hodgkin's lymphomas associated with Hodgkin's disease. Am J Surg Pathol 1994;18:48-61.
4. Carrato A, Filippa D, Koziner B. Hodgkin's disease after treatment of non-Hodgkin's lymphoma. Cancer 1987;60:887-96.
5. Travis LB, Gonzalez CL, Hankey BF, Jaffe ES. Hodgkin's disease following non-Hodgkin's lymphoma. Cancer 1992;69:2337-42.
6. Aguilera NS, Howard LN, Brissette MD, Abbondanzo SL. Hodgkin's disease and an extranodal marginal zone B-cell lymphoma in the small intestine: An unusual composite lymphoma. Mod Pathol 1996;9:1020-6.
7. Dunphy CH, Crave JL, Emerson WA. Demonstration of composite nodal B-cell lymphoma and subsequent Hodgkin's disease by flow cytometry and immunohistochemistry. Case report and review of the literature. Arch Pathol Lab Med 1997;121:637-40.
8. Variakojis D, Anastasi J. Unresolved issues concerning Hodgkin's disease and its relationship to non-Hodgkin's lymphoma. Am J Clin Pathol 1993;99:436-44.
9. Lehman CM, Sarago C, Nasim S, Comerford J, Karcher DS, Garrett CT. Comparison of PCR with Southern hybridization for the routine detection of immunoglobulin heavy chain gene rearrangements. Am J Clin Pathol 1995;103:171-6.
10. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 1994;84:1361-92.
11. Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classification of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage. Cancer 1982;49:2112-35.
12. Shimizu K, Hara K, Kunii A. Weekly CHOP for the treatment of advanced intermediate and high-grade non-Hodgkin's lymphoma. Am J Clin Oncol 1989;12:195-200.
13. Baddoura FK, Chan WC, Masih AS, Mitchell D, Sun NCJ, Weisen-burger DD.T-cell-rich B-cell lymphoma. A clinicopathologic study of eight cases. Am J Clin Pathol 1995;103:65-75.
14. Shimizu K, Kara K, Kunii A. Non-Hodgkin's lymphoma following Hodgkin's disease. A case report and immunohistochemical corroboration. Am J Clin Pathol 1986;86:370-4.
15. Shimizu K, Hirano M, Maruyama F, et al. T-cell malignancy following B-cell lymphoma in remission. Am J Clin Pathol 1989;92:362-6.
16. Yatabe Y, Mori N, Oka K, et al. Fatal Epstein-Barr virus-associated lymphoproliferative disorder in childhood. Arch Pathol Lab Med 1995;119:409-17.
17. Yatabe Y, Oka K, Asai J, Mori N. Poor correlation between clonal immunoglobulin gene rearrangement and immunoglobulin gene transcription in Hodgkin's disease. Am J Pathol 1996; 149:1351-61.
18. Schmid C, Pan L, Diss T, Isaacson PG. Expression of B-cell antigens by Hodgkin's and Reed-Sternberg cells. Am J Pathol 1991;139:701-7.
19. Orazi A, Jiang B, Lee CH, et al. Correlation between presence of clonal rearrangements of immunoglobulin heavy chain genes and B-cell antigen expression in Hodgkin's disease. Am J Clin Pathol 1995;104:413-8.
20. Siebert JD, McClure SP, Banks PM, Gulley ML. Hodgkin's disease, mixed cellularity type, with a B-cell phenotype. Report of a case and literature review. Arch Pathol Lab Med 1995;119:474-9.
21. Kuppers R, Hansmann ML, Diehl V, Rajewsky K. Molecular single cell analysis of Hodgkin and Reed-Sternberg cells. Mol Med Today 1995;1:26-30.
22. Stein H, Hummel M, Marafioti T, Anagnostopoulos I, Foss HD. Molecular biology of Hodgkin's disease. In:Wotherspoon AC, editor. Lymphoma. New York: Cold Spring Harbor Laboratory Press, 1997:107-23.